UnknownNCT04815902
Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
PHASE1 · PHASE2 · 100 planned enrolment
- Countries listed
- 1
- Registry update
- April 16, 2024
immortal.lifeTrial registrations containing the exact intervention label Losartan.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · PHASE2 · 100 planned enrolment
PHASE1 · PHASE2 · 6 planned enrolment